mRNA vaccines in disease prevention and treatment

G Zhang, T Tang, Y Chen, X Huang… - Signal transduction and …, 2023 - nature.com
Abstract mRNA vaccines have emerged as highly effective strategies in the prophylaxis and
treatment of diseases, thanks largely although not totally to their extraordinary performance …

Barrier membranes for guided bone regeneration (gbr): A focus on recent advances in collagen membranes

Y Ren, L Fan, S Alkildani, L Liu, S Emmert… - International journal of …, 2022 - mdpi.com
Guided bone regeneration (GBR) has become a clinically standard modality for the
treatment of localized jawbone defects. Barrier membranes play an important role in this …

Influence of the TGF-β superfamily on osteoclasts/osteoblasts balance in physiological and pathological bone conditions

J Jann, S Gascon, S Roux, N Faucheux - International journal of …, 2020 - mdpi.com
The balance between bone forming cells (osteoblasts/osteocytes) and bone resorbing cells
(osteoclasts) plays a crucial role in tissue homeostasis and bone repair. Several hormones …

Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine

H Kwon, M Kim, Y Seo, YS Moon, HJ Lee, K Lee, H Lee - Biomaterials, 2018 - Elsevier
The field of gene therapy has evolved over the past two decades after the first introduction of
nucleic acid drugs, such as plasmid DNA (pDNA). With the development of in vitro …

[HTML][HTML] RNA-based scaffolds for bone regeneration: application and mechanisms of mRNA, miRNA and siRNA

Q Leng, L Chen, Y Lv - Theranostics, 2020 - ncbi.nlm.nih.gov
Abstract Globally, more than 1.5 million patients undergo bone graft surgeries annually, and
the development of biomaterial scaffolds that mimic natural bone for bone grafting remains a …

BMP-2 and VEGF-A modRNAs in collagen scaffold synergistically drive bone repair through osteogenic and angiogenic pathways

Y Geng, H Duan, L Xu, N Witman, B Yan, Z Yu… - Communications …, 2021 - nature.com
Bone has a remarkable potential for self-healing and repair, yet several injury types are non-
healing even after surgical or non-surgical treatment. Regenerative therapies that induce …

Gene-and RNAi-activated scaffolds for bone tissue engineering: Current progress and future directions

NZ Laird, TM Acri, K Tingle, AK Salem - Advanced drug delivery reviews, 2021 - Elsevier
Large bone defects are usually managed by replacing lost bone with non-biological
prostheses or with bone grafts that come from the patient or a donor. Bone tissue …

mRNA–a game changer in regenerative medicine, cell-based therapy and reprogramming strategies

O Chabanovska, AM Galow, R David… - Advanced Drug Delivery …, 2021 - Elsevier
After thirty years of intensive research shaping and optimizing the technology, the approval
of the first mRNA-based formulation by the EMA and FDA in order to stop the COVID-19 …

Nanoparticle-based delivery of CRISPR/Cas9 genome-editing therapeutics

BE Givens, YW Naguib, SM Geary, EJ Devor… - The AAPS journal, 2018 - Springer
The recent progress in harnessing the efficient and precise method of DNA editing provided
by CRISPR/Cas9 is one of the most promising major advances in the field of gene therapy …

[HTML][HTML] Synthetic mRNA–emerging new class of drug for tissue regeneration

ER Balmayor - Current opinion in biotechnology, 2022 - Elsevier
Highlights•mRNA therapeutics could represent the next generation drug for tissue
restoration in regenerative medicine.•Non-immunogenic mRNA can be generated by the …